Jp. Cai et al., BORON-CONTAINING POLYAMINES AS DNA TARGETING AGENTS FOR NEUTRON-CAPTURE THERAPY OF BRAIN-TUMORS - SYNTHESIS AND BIOLOGICAL EVALUATION, Journal of medicinal chemistry, 40(24), 1997, pp. 3887-3896
Three series of new boron-containing spermidine/spermine (SPD/SPM) ana
logues have been synthesized: N1(-) and N-5-(4-carboranylbutyl) SPD/SP
M derivatives (SPD-1, SPD-5, SPM-1, SPM-5); N-1,N-10-diethyl-N-5-(4-ca
rboranylbutyl)spe (DESPD-5), N-1,N-14-diethyl-N-5-(4-carboranylbutyl)s
permine (DESPM-5); and N-5,N-10-bis(4-carboranylbutyl)spermine (SPM-5,
10). In vitro studies using rat F98 glioma cells have shown that these
polyamines retain the ability to displace ethidium bromide from calf
thymus DNA and are rapidly taken up by F98 glioma cells. However, thei
r cytotoxicities, especially those with terminal N-substituted (SPD-1,
SPM-1) boron compounds, are greater than those of SPD/SPM. Neverthele
ss, the groundwork has been created for a new class of boron-containin
g compounds that maybe useful for boron neutron capture therapy of tum
ors.